News

News about advances made possible through IPIRA's work, such as innovations commercialized, campus partnerships with industry, and companies born out of licensing UC Berkeley intellectual property rights.

All News

October 6, 2021

CalWave Commissions Open-water Wave Energy Pilot

Link

Intellia Phase 1/2 Clinical Trial Authorized for Hereditary Angioedema Treatment

Link

September 23, 2021

GenEdit Closes $26 Million in Series A Financing

Link

September 14, 2021

Ambi Robotics Announces $26 Million Series A Funding Led By Tiger Global

Link

September 9, 2021

Mammoth Biosciences Raises $195 Million, Vaulting Its Crispr Tech to Unicorn Status

Link

September 8, 2021

Contest Challenges Inventors to Harness Wave Power to Desalinate Seawater

Link

Breakthrough "Air Stable" Quantum Dot Component Enters Mass Production

Link

August 27, 2021

14 Best Berkeley Medical Device Startups Revolutionizing Healthcare

Link

August 19, 2021

Huue and Ginkgo Bioworks Partner to Accelerate Production of Sustainable Dyes

Link

August 12, 2021

AngioDynamics Receives FDA Approval for PRESERVE Study

Link

Iaterion, Inc. Awarded NIH Grant for Nuclear Receptor Coligand Platform

Link

August 11, 2021

FDA-approved Trial Evaluates AngioDynamics’ NanoKnife for Prostate Tissue Ablation

Link

July 28, 2021

Study Reveals Gene Involved in Stem Rust Resistance in Wheat

https://www.isaaa.org/kc/cropbiotechupdate/article/default.asp?ID=18918

July 23, 2021

Caribou Raises $304M in One of Gene Editing's Most Lucrative IPOs

Link

July 21, 2021

Berkeley startup aims to be a game changer in autoimmune disease therapy

Link

July 19, 2021

With Focus on the 'Undruggable,' Biotech Raises $88.5M Series B from IPO-minded Investors

Link

July 14, 2021

Enable Biosciences Supports California Department of Public Health's CalScope Program to Survey COVID-19 Antibodies from Infection and Vaccination

Link

July 13, 2021

Tenaya Therapeutics Preclinical Research Supports Product Candidate for Heart Disease Indications

Link

July 12, 2021

Clinical Trial of CRISPR-Edited Cell Therapy Launched for Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

Link

July 3, 2021

Cannabinoids Are the Next Big Thing in the Pot Industry, But Who Can Mass-Produce It?

https://observer.com/2021/07/cannabinoids-are-the-next-big-thing-in-the-...